205 related articles for article (PubMed ID: 19216226)
1. Release of anti-inflammatory drugs from a silicone elastomer matrix system.
Snorradóttir BS; Gudnason PI; Scheving R; Thorsteinsson F; Másson M
Pharmazie; 2009 Jan; 64(1):19-25. PubMed ID: 19216226
[TBL] [Abstract][Full Text] [Related]
2. Experimental design for optimizing drug release from silicone elastomer matrix and investigation of transdermal drug delivery.
Snorradóttir BS; Gudnason PI; Thorsteinsson F; Másson M
Eur J Pharm Sci; 2011 Apr; 42(5):559-67. PubMed ID: 21371556
[TBL] [Abstract][Full Text] [Related]
3. Controlled release of a model antibacterial drug from a novel self-lubricating silicone biomaterial.
Malcolm RK; McCullagh SD; Woolfson AD; Gorman SP; Jones DS; Cuddy J
J Control Release; 2004 Jun; 97(2):313-20. PubMed ID: 15196758
[TBL] [Abstract][Full Text] [Related]
4. Persistence of antimicrobial activity through sustained release of triclosan from pegylated silicone elastomers.
McBride MC; Karl Malcolm R; David Woolfson A; Gorman SP
Biomaterials; 2009 Dec; 30(35):6739-47. PubMed ID: 19765822
[TBL] [Abstract][Full Text] [Related]
5. Characterization of silicone elastomer vaginal rings containing HIV microbicide TMC120 by Raman spectroscopy.
Bell SE; Dennis AC; Fido LA; Malcolm RK; Sirimuthu NM; Toner CF; Woolfson AD
J Pharm Pharmacol; 2007 Feb; 59(2):203-7. PubMed ID: 17270074
[TBL] [Abstract][Full Text] [Related]
6. Fabrication of non-dissolving analgesic suppositories using 3D printed moulds.
Sun Y; Ruan X; Li H; Kathuria H; Du G; Kang L
Int J Pharm; 2016 Nov; 513(1-2):717-724. PubMed ID: 27686053
[TBL] [Abstract][Full Text] [Related]
7. Effect of lipophilic counter-ions on membrane diffusion of benzydamine.
Sarveiya V; Templeton JF; Benson HA
Eur J Pharm Sci; 2005 Sep; 26(1):39-46. PubMed ID: 15950443
[TBL] [Abstract][Full Text] [Related]
8. Effect of nano-oxide concentration on the mechanical properties of a maxillofacial silicone elastomer.
Han Y; Kiat-amnuay S; Powers JM; Zhao Y
J Prosthet Dent; 2008 Dec; 100(6):465-73. PubMed ID: 19033031
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of a novel conjugate of ibuprofen with 3-hydroxybutyric acid oligomers.
Stasiak P; Ehrhardt C; Juzwa M; Sznitowska M
J Pharm Pharmacol; 2009 Aug; 61(8):1119-24. PubMed ID: 19703357
[TBL] [Abstract][Full Text] [Related]
10. Influence of silicone elastomer solubility and diffusivity on the in vitro release of drugs from intravaginal rings.
Malcolm K; Woolfson D; Russell J; Tallon P; McAuley L; Craig D
J Control Release; 2003 Jun; 90(2):217-25. PubMed ID: 12810304
[TBL] [Abstract][Full Text] [Related]
11. Influence of ethanol on the solubility, ionization and permeation characteristics of ibuprofen in silicone and human skin.
Watkinson RM; Herkenne C; Guy RH; Hadgraft J; Oliveira G; Lane ME
Skin Pharmacol Physiol; 2009; 22(1):15-21. PubMed ID: 19088498
[TBL] [Abstract][Full Text] [Related]
12. Viscosity of hydrogel pharmaceutical products and the rate of diffusion of ibuprofen hydrotropic binding through model phase boundary in vitro.
Zgoda MM; Kołodziejska J; Nachajski MJ
Polim Med; 2007; 37(1):3-24. PubMed ID: 17703720
[TBL] [Abstract][Full Text] [Related]
13. Altering the physical properties of silicone elastomers for medical device applications.
Musolf MC
Med Device Technol; 1990; 1(1):26-9. PubMed ID: 10148172
[TBL] [Abstract][Full Text] [Related]
14. Propranolol forms affect properties of Carbopol-containing extruded-spheronized beads.
Paker-Leggs S; Neau SH
Int J Pharm; 2008 Sep; 361(1-2):169-76. PubMed ID: 18601988
[TBL] [Abstract][Full Text] [Related]
15. [Effect of fillers on the strength of silicone systems].
Snejdrová E; Zelenka J; Rehula M
Ceska Slov Farm; 2002 Jul; 51(4):200-4. PubMed ID: 12183909
[TBL] [Abstract][Full Text] [Related]
16. Determination of ibuprofen solubility in wax: a comparison of microscopic, thermal and release rate techniques.
Oladiran GS; Batchelor HK
Eur J Pharm Biopharm; 2007 Aug; 67(1):106-11. PubMed ID: 17321730
[TBL] [Abstract][Full Text] [Related]
17. Controlling drug release from non-aqueous environments: Moderating delivery from ocular silicone oil drug reservoirs to combat proliferative vitreoretinopathy.
Cauldbeck H; Le Hellaye M; Long M; Kennedy SM; Williams RL; Kearns VR; Rannard SP
J Control Release; 2016 Dec; 244(Pt A):41-51. PubMed ID: 27845192
[TBL] [Abstract][Full Text] [Related]
18. Initial salt screening procedures for manufacturing ibuprofen.
Lee T; Wang YW
Drug Dev Ind Pharm; 2009 May; 35(5):555-67. PubMed ID: 19005918
[TBL] [Abstract][Full Text] [Related]
19. The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity.
Salústio PJ; Feio G; Figueirinhas JL; Pinto JF; Cabral Marques HM
Eur J Pharm Biopharm; 2009 Feb; 71(2):377-86. PubMed ID: 18977436
[TBL] [Abstract][Full Text] [Related]
20. High speed DSC (hyper-DSC) as a tool to measure the solubility of a drug within a solid or semi-solid matrix.
Gramaglia D; Conway BR; Kett VL; Malcolm RK; Batchelor HK
Int J Pharm; 2005 Sep; 301(1-2):1-5. PubMed ID: 16061335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
